Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000472459 | SCV000559633 | benign | Spinocerebellar ataxia type 19/22 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001696884 | SCV000719088 | likely benign | not provided | 2020-07-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000620105 | SCV000737565 | benign | Cardiovascular phenotype | 2016-06-07 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002496827 | SCV002797857 | likely benign | Spinocerebellar ataxia type 19/22; Brugada syndrome 9 | 2021-08-17 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000600534 | SCV001922190 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001696884 | SCV001931133 | likely benign | not provided | no assertion criteria provided | clinical testing |